Background Long-term administration of beta-adrenergic blockers to patients after myocardial
infarction improves survival. However, physicians are reluctant to administer beta-blockers …

Background Nesiritide is approved in the United States for early relief of dyspnea in patients
with acute heart failure. Previous meta-analyses have raised questions regarding renal …

Background. Despite the fact that coronary artery disease is the leading cause of death
among women, previous studies have suggested that physicians are less likely to pursue an …

Objectives : The goal of this study was to determine the prevalence of worsening renal
function (WRF) among hospitalized heart failure (HF) patients, clinical predictors of WRF, and …

Background Carvedilol has improved the symptomatic status of patients with moderate to
severe heart failure in single-center studies, but its clinical effects have not been evaluated in …

… Author links open overlay panel Stephen S. Gottlieb MD 1 , William Abraham MD 2 , Javed
Butler MD 3 , Daniel E. Forman MD 4 , Evan Loh MD 5 , Barry M. Massie MD 6 , Christopher M…

Background In patients who have had a myocardial infarction, the long-term risk of stroke
and its relation to the extent of left ventricular dysfunction have not been determined. We …

Objectives : The goal of this study was to determine the prevalence of depression in an out-patient
heart failure (HF) population; its relationship to quality of life (QOL); and the impact of …

Maintenance of blood volume, vascular tone, and hemo-dynamic stability depends on a set
of elegant interactions between the heart and kidney. For some time, physicians have …

Background—We determined the short-term hemodynamic and clinical effects of
levosimendan, a novel calcium-sensitizing agent, in patients with decompensated heart failure. …